Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.

@article{Papatheodoridis2016AddressingBT,
  title={Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.},
  author={Georgios Papatheodoridis and Howard Christopher Imp Thomas and Christina Golna and Mauro Bernardi and Matilde Carballo and Markus Cornberg and Georgios N Dalekos and B{\"u}lent Deḡertekin and Spyridon P. Dourakis and Robert Flisiak and David Goldberg and Charles Gore and Ioannis G Goulis and Stephanos J. Hadziyannis and Georgios Kalamitsis and Panos Kanavos and Achim Kautz and Ioannis George Koskinas and Bruno Rodrigues Leite and Melpomeni Malliori and Spilios G Manolakopoulos and Mojca Maticic and Vassiliki Papaevangelou and Alessandro Pirona and Daniele Prati and Maria Raptopoulou-Gigi and Tatjana Reic and Geert Robaeys and Eberhard Schatz and Kyriakos Souliotis and Yiannis Tountas and Stefan Zbyszko Wiktor and David J Wilson and John Yfantopoulos and Angelos Hatzakis},
  journal={Journal of viral hepatitis},
  year={2016},
  volume={23 Suppl 1},
  pages={
          1-12
        }
}
In the WHO-EURO region, around 28 million people are currently living with chronic viral hepatitis, and 120,000 people die every year because of it. Lack of awareness and understanding combined with the social stigma and discrimination exacerbate barriers related to access to prevention, diagnosis and treatment services for those most in need. In addition, the persisting economic crisis has impacted on public health spending, thus posing challenges on the sustainable investment in promotion… CONTINUE READING
BETA
3
Twitter Mentions

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS